Axsome Therapeutics, Inc. (AXSM) NASDAQ
245.64
+10.5(+4.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
245.64
+10.5(+4.47%)
Currency In USD
| Market Cap | 9.09B |
| Enterprise Value | 9B |
| P/E Ratio | -66.79 |
| PEG Ratio | -1.49 |
| Price/Sales Ratio | 17.85 |
| Price/Book Ratio | 230.39 |
| Enterprise/Revenue | 17.72 |
| Enterprise/EBITDA | -72.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.27 |
| Operating Margin | -0.25 |
| Return On Assets | -0.26 |
| Return On Equity | -2.6 |
| Revenue | 638.5M |
| Revenue/Share | 13.83 |
| Gross Profit | 591.02M |
| EBITDA | -168.08M |
| Net Income | -183.17M |
| Diluted EPS | -3.68 |
| Total Cash | 305.11M |
| Total Cash/Share | 5.96 |
| Total Debt | 216.71M |
| Total Debt/Equity | 3.97 |
| Current Ratio | 1.39 |
| Book Value Per Share | 1.07 |
| 52-Week Change | 123.57 |
| 52-Week High | 246.41 |
| 52-Week Low | 96.09 |
| Moving Average 50 Days | 204.6 |
| Moving Average 200 Days | 162.89 |
| Average Volume | 715,588 |
| Shares Outstanding | 51.46M |
| % Held by Institutions | 76.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |